العربية

Archive for August, 2010

The Nebraska Medical Center Again Recognized for Outstanding Stroke and Cardiovascular Care

Omaha, Neb – For the second year in a row, The Nebraska Medical Center has earned the American Heart Association/American Stroke Association’s Get With The Guidelines® Stroke Gold Plus Achievement Award.

 
Get With The Guidelines is a hospital-based quality-improvement program designed to ensure hospitals consistently care for cardiac and stroke patients following the most up-to-date guidelines and recommendations. The program addresses coronary artery disease, heart failure and stroke. Currently more than 1,400 hospitals participate in the program.

 
Stroke is the leading cause of disability in the United States and the third leading cause of death.

 
The stroke team at The Nebraska Medical Center is poised to help patients seven days a week, 24 hours a day. The goal is to treat patients as soon as possible after the onset of stroke symptoms.

 
“Reducing stroke’s devastating effects and preventing it can only be achieved with the right dedication, staffing, organization, and treatment,” said Pierre Fayad, M.D., Director of the Stroke Center at The Nebraska Medical Center and Reynolds Centennial Professor & Chairman of Neurological Sciences at UNMC. “This recognition for our stroke center reassures our patients, their families and our community, that our staff and dedication allow us to deliver such complex care around the clock, and achieve similar results to the very best centers around the country.

 
To receive the award, The Nebraska Medical Center achieved 85 percent or higher adherence to all Get With The Guidelines-Stroke Performance Achievement indicators for two or more consecutive 12-month intervals and achieved 75 percent or higher compliance with six of 10 Get
With The Guidelines-Stroke Quality Measures, which are reporting initiatives to measure quality of care.

 

“This award is another demonstration of The Nebraska Medical Center’s commitment to being among the top hospitals in the country for providing the best proven and effective stroke care,” said Dr. Fayad. “We need to continue focusing on providing care according to the latest reliable scientific findings, and adapting them as quickly and efficiently as possible to treat stroke patients with evidence-based strategies.”

 
The Nebraska Medical Center and the other Get With The Guidelines® recipient hospitals will be recognized in a special advertisement in the upcoming “Best Hospitals” issue of US News and World Report.

 
“The American Heart Association is pleased to recognize its top Get With The Guidelines participants,” said. Lee Schwamm, M.D., national chairman of the Get With The Guidelines steering committee, associate professor of neurology at Harvard Medical School and Vice Chairman of Neurology at Massachusetts General Hospital. “Healthcare providers who use Get With The Guidelines are armed with the latest evidence-based guidelines and immediate access to clinical decision support, using a set of tools that have been shown to improve delivery of evidence-based care. The goal of this initiative is to improve the quality of life and help reduce deaths and disability among patients with heart disease and stroke.”

 
Schwamm added, “Published scientific studies are providing us with more and more evidence that Get With The Guidelines works. Patients are getting the right care they need when they need it. That’s resulting in improved survival.”

 
About The Nebraska Medical Center
With a reputation for excellence, innovation and extraordinary patient care, The Nebraska Medical Center has earned J.D. Power and Associates’ Hospital of Distinction award for inpatient services for four consecutive years. It is a US News & World Report 2008 “Best Hospital” for Cancer, Neurology and Neurosurgery. It also received the 2009 Consumer Choice Award, a mark of patient satisfaction as selected by healthcare consumers and has achieved Magnet recognition status for nursing excellence, Thomson Reuters 100 Top Hospitals Performance Improvement Leader recognition, as well as the Award of Progress from the state of Nebraska’s Edgerton Quality Awards Program. As the teaching hospital for the University of Nebraska Medical Center, this 624 licensed bed academic medical center has an international reputation for providing solid organ and bone marrow transplantation services and is well known nationally and regionally for its oncology, neurology and cardiology programs. The Nebraska Medical Center can be found online at www.nebraskamed.com

 

About Get With The Guidelines
Get With The Guidelines® is the American Heart Association/American Stroke Association’s hospital-based quality improvement program that empowers healthcare teams to save lives and reduce healthcare costs by helping hospitals follow evidence-based guidelines and recommendations. For more information, visit heart.org/quality.

Lymphoma Research Foundation News Room:Featured LRF Researcher

Chief, Division of Hematology/Oncology and Professor of Medicine at the University of Nebraska Medical Center
Since being elected to the Lymphoma Research Foundation’s (LRF) Scientific Advisory Board (SAB) in 2001, Dr. Julie Vose, the Neumann M. and Mildred E. Harris Professorial Chair and Chief of the Oncology/Hematology Section in the Department of Internal Medicine at the University of Nebraska Medical Center (UNMC), has taken an active role in the Foundation’s leadership. Along with new SAB member Ranjana Advani, MD, Dr. Vose has formed a new LRF consortium focusing on T-cell lymphoma, which develops from abnormal T-lymphocytes. The group plans to hold meetings to discuss standards of care, conduct clinical trials and potentially award grants and hold workshops in the future assuming fundraising efforts are successful. 
 
“LRF has witnessed great success with its Mantle Cell Lymphoma Consortium, so the T-cell consortium is hoping to have similar impact in identifying new potential targets for therapies and having interactive multidisciplinary research grants funded by the LRF,” she said.

 
 
Dr. Vose has also contributed to countless other LRF programs and publications. She has served as an expert consultant for LRF’s Chicago Lymphoma Rounds program for the past two years. In this role, she reviews and approves case study presentations for Continuing Medical Education credits at the events which draw leading lymphoma experts from across the Greater Chicago area. She is a frequent member of the speaking faculty for the national Lymphoma Workshop program and co-chaired the North American Educational Forum on Lymphoma in 2008. In 2009, she was a speaker for LRF’s teleconference “Update on Lymphoma Treatment Options from the 2009 American Society of Hematology (ASH) Annual Meeting” and she has served as a contributor and an editor for the Foundation’s numerous patient resources, including disease-specific booklets and fact sheets.
As a medical student at the University of Nebraska Medical School, Dr. Vose, curious about new discoveries and treatments in the field of lymphoma, pursued her research interests with distinguished researcher, James Armitage, MD. She is proud of the fact that based on findings from this research, “we are able to modify treatments to be more specific for subtypes of lymphomas.”  After medical school, Dr. Vose completed both her residency and fellowship at UNMC.

 
Driven by the exhilaration of new discoveries and enhancements in therapies, Dr. Vose now focuses her research on novel therapies for different subtypes of lymphomas. As for what she finds most exciting in modern lymphoma research, Dr. Vose said, “gene expression and [Single Nucleotide Polymorphism] work that is going on in individual lymphomas, which may direct patients’ individualized therapy in the future.”

 
 
Dr. Vose has played a significant role in moving several novel agent lymphoma treatments from Phase I to Phase II and Phase III clinical trials. She recently completed a Phase III trial in the Blood and Marrow Transplant Clinical Trials Network on the Bexxar/BEAM protocol, which focused on the addition of radiolabeled antibodies to high dose chemotherapy and autologous stem cell transplantation.

 
Her research has led her to be an advisor and member of several advisory boards. Most recently, the American Society of Clinical Oncology (ASCO) elected Dr. Vose to the Undesignated Specialty seat on its Board of Directors. Her 3-year term started in June and she is the only lymphoma specialist on the 20-member board.

 
When asked for the most important piece of advice she would give to a newly diagnosed lymphoma patient, Dr. Vose said “to conduct plenty of research and to make sure to be treated by a lymphoma specialist.”

 

Posted: Lymphoma Research Foundation News

Loading